Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease

被引:51
作者
Goldsmith, Kimberley A. [1 ,2 ,3 ]
Dyer, Matthew T. [4 ,5 ]
Buxton, Martin J. [4 ]
Sharples, Linda D. [1 ,2 ]
机构
[1] Papworth Hosp NHS Trust, Cambridge, England
[2] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England
[3] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
[4] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England
[5] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London SW1X 8PG, England
关键词
LASER REVASCULARIZATION; COST-EFFECTIVENESS; ANGINA-PECTORIS; STANDARD EQ-5D; EUROQOL; VALIDATION; TRIAL;
D O I
10.1186/1477-7525-8-54
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis. The EQ-5D has been widely used in many patient groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D may not be gathered. This study aimed to assess whether demographic and clinical outcome variables, including scores from a disease specific measure, the Seattle Angina Questionnaire (SAQ), could be used to predict, or map, the EQ-5D index value where it is not available. Methods: Patient-level data from 5 studies of cardiac interventions were used. The data were split into two groups approximately 60% of the data were used as an estimation dataset for building models, and 40% were used as a validation dataset. Forward ordinary least squares linear regression methods and measures of prediction error were used to build a model to map to the EQ-5D index. Age, sex, a proxy measure of disease stage, Canadian Cardiovascular Society (CCS) angina severity class, treadmill exercise time (ETT) and scales of the SAQ were examined. Results: The exertional capacity (ECS), disease perception (DPS) and anginal frequency scales (AFS) of the SAQ were the strongest predictors of the EQ-5D index and gave the smallest root mean square errors. A final model was chosen with age, gender, disease stage and the ECS, DPS and AFS scales of the SAQ. ETT and CCS did not improve prediction in the presence of the SAQ scales. Bland-Altman agreement between predicted and observed EQ-5D index values was reasonable for values greater than 0.4, but below this level predicted values were higher than observed. The 95% limits of agreement were wide (-0.34, 0.33). Conclusions: Mapping of the EQ-5D index in cardiac patients from demographics and commonly measured cardiac outcome variables is possible; however, prediction for values of the EQ-5D index below 0.4 was not accurate. The newly designed 5-level version of the EQ-5D with its increased ability to discriminate health states may improve prediction of EQ-5D index values.
引用
收藏
页数:13
相关论文
共 28 条
[1]  
[Anonymous], GUIDE METHODS TECHNO
[2]   Using the EuroQol 5-D in the Catalan General Population: Feasibility and Construct Validity [J].
X. Badia ;
A. Schiaffino ;
J. Alonso ;
M. Herdman .
Quality of Life Research, 1998, 7 (4) :311-322
[3]  
Brazier J, 1999, Health Technol Assess, V3, pi
[4]   A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures [J].
Brazier, John E. ;
Yang, Yaling ;
Tsuchiya, Aki ;
Rowen, Donna Louise .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2010, 11 (02) :215-225
[5]  
BRUCE RA, 1969, B NEW YORK ACAD MED, V45, P1288
[6]   A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris [J].
Campbell, HE ;
Tait, S ;
Buxton, MJ ;
Sharples, LD ;
Caine, N ;
Schofield, PM ;
Wallwork, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 20 (02) :312-318
[7]   Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris [J].
Campbell H.E. ;
Tait S. ;
Sharples L.D. ;
Caine N. ;
Gray T.J. ;
Schofield P.M. ;
Buxton M.J. .
The European Journal of Health Economics, 2005, 6 (4) :288-297
[8]   Modeling valuations for EuroQol health states [J].
Dolan, P .
MEDICAL CARE, 1997, 35 (11) :1095-1108
[9]  
Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO
[10]  
2-N